7 Reasons America's Mental Health Industry Is a Threat to Our Sanity. January 5, 2012 | Like this article? Join our email list: Stay up to date with the latest headlines via email. Why do some of us become dissident mental health professionals? The majority of psychiatrists, psychologists and other mental health professionals “go along to get along” and maintain a status quo that includes drug company corruption, pseudoscientific research and a “standard of care” that is routinely damaging and occasionally kills young children.
If that sounds hyperbolic, then you probably have not heard of Rebecca Riley, and how the highest levels of psychiatry described her treatment as “appropriate and within responsible professional standards.” When Rebecca Riley was 28 months old, based primarily on the complaints of her mother that she was “hyper” and had difficulty sleeping, psychiatrist Kayoko Kifuji, at the Tufts-New England Medical Center in Boston, Massachusetts, diagnosed Rebecca with attention deficit hyperactivity disorder (ADHD). Kifuji’s fate? 1. 7 Reasons America's Mental Health Industry Is a Threat to Our Sanity. How Medicalizing Grief Turns Into Dollars. Treating Depression: Is there a placebo effect? UNITE: United Non-Profits and Individuals for Truth and Ethics - Home. After The Risperdal Trial, J&J Looks More Like Humpty-Dumpty. GENERATION RX - a film by Kevin P. Miller - Trailer 2.
J&J Pushed Risperdal for Kids Without Approval, Memo Shows. (Updates with details from Janssen executive’s testimony starting in fifth paragraph.) Jan. 17 (Bloomberg) -- A Johnson & Johnson unit marketed its Risperdal drug in 2004 to doctors working with troubled children even though regulators hadn’t approved the drug for those patients, company records show. Officials of J&J’s Janssen unit pushed salespeople in Texas to “flood clinics with Risperdal stuff” as part of a 2004 campaign to increase prescriptions for the anti-psychotic drug written for children and adolescents, according to an internal memo put into evidence today in state court in Austin, Texas. The U.S. Food and Drug Administration didn’t approve Risperdal for any pediatric use until 2006. Texas officials contend New Brunswick, New Jersey-based J&J, the world’s largest health-care products company, defrauded the state Medicaid program by promoting Risperdal for uses not approved by U.S. regulators, including for children with psychiatric disorders.
The case is Texas v. ABC NEWS - DAY 3: Mind-Altering Psych Drugs for a 7-Year-Old. ABC NEWS - DAY 2: -- Psychiatrists Put Kids at Risk With Mind-Altering Drugs. ABC NEWS - DAY 1: -- U.S. Government Fails to Oversee Treatment of Children With Mind-Altering Drugs. 12 year old Testifies in U S Senate Hearing. J&J Said to Settle Texas Risperdal Anti-Psychotic Drug Case. Johnson & Johnson (JNJ) agreed to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug, ending a trial over the allegations.
J&J’s settlement will resolve claims it defrauded the state’s Medicaid program by promoting Risperdal for uses not approved by U.S. regulators, including for children with psychiatric disorders, the people said today. The state also claimed New Brunswick, New Jersey-based drugmaker downplayed the risk of Risperdal. J&J spokeswoman Teresa Mueller didn’t have an immediate comment on the settlement. J&J, the world’s largest health-care products company, and its Janssen unit agreed to the accord in the middle of a four- week trial of the state’s lawsuit, which sought at least $579 million in damages over the companies’ Risperdal marketing practices, the people said. Risperdal, also known as Risperidone, Ridal, Rispen is an antipsychotic medication. Close Close Open The Texas case is Texas v. Home. Wall. Jenelle's story: Tardive Dyskinesia (Dystonia) from Psychiatric Drugs.